Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine for cognitive dysfunction in bipolar disorder
NCT00195845Phase 4Completed
- Sponsor
- Cambridge Health Alliance
- Start
- Apr 2003
- Primary completion
- Sep 2006
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of galantamine in bipolar disorder (BD), sponsored by Cambridge Health Alliance. Started Apr 2003; status: completed.
02
Drugs
galantamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00195845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195845.